Answering patients' needs: Oral alternatives to intravenous therapy

Oncologist

Volumn 6, Issue SUPPL. 4, 2001, Pages 12-16

  Borner, Markus ^a,f   Scheithauer, Werner ^b   Twelves, Chris ^c   Maroun, Jean ^d   Wilke, Hansjochen ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

^e KLINIKEN ESSEN MITTE   (Germany)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

5 FU; Capecitabine; Colorectal cancer; Fluoropyrimidines; Oral; UFT

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; UFT;

CANCER THERAPY; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE COURSE; DISTRESS SYNDROME; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; METASTASIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0034791938     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.6-suppl_4-12     Document Type: Conference Paper

References (11)

1. A study of quality of life in cancer patients receiving palliative chemotherapy
2. A comparative assessment of home versus hospital comprehensive treatment for advanced cancer patients
3. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer
4. Complications of an implantable venous access device (Port-a-Cath®) during intermittent continuous infusion of chemotherapy
5. Patient preferences for oral versus intravenous palliative chemotherapy
6. A randomized crossover trial comparing oral UFT (uracil/tegafur) + leucovorin (LV) and intravenous fluorouracil (FU) + LV for patient preference and pharmacokinetics in advanced colorectal cancer
7. Capecitabine as first-line treatment for colorectal cancer (CRC): Integrated results of 1207 patients (pts) from 2 randomised, phase III studies
8. Multicenter phase III study of 5-fluorouracil (5-FU) or UFT™ in combination with leucovorin (LV) in patients with metastatic colorectal cancer
9. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French Intergroup study
10. 24h) with or without folinic acid (FA) vs. bolus 5-FU/FA (NCCTG/Mayo) in advanced colorectal cancer (CRC): A randomized phase III study of the EORTC GITCCG and the AIO
11. Infusional 5-fluorouracil can be a pain in the neck: A case for repositioning displaced Hickman lines